Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection

The Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI) provides practical and scientific advice to the government on minimising the risk of healthcare associated infections.


  • Professor Mike Sharland (Chair)
  • Professor Mark Wilcox (deputy-Chair)
  • Ms Jane Binyon (Lay member)
  • Dr Nick Brown
  • Dr Kieran Hand
  • Professor Alastair Hay
  • Professor Alan Johnson
  • Mr Martin Kiernan
  • Professor David Livermore
  • Professor Michael Moore
  • Dr Peter Moss
  • Mrs Judith Potter
  • Dr Sarah Tonkin-Crine
  • Professor Andrew Peter Wilson
  • Professor Neil Woodford

Code of practice

Members' code of practice (PDF, 89.6KB, 11 pages)

Members’ interests

Register of Members' Interests (PDF, 89.4KB, 2 pages)


Future Meeting Dates:

  • 18 June 2018
  • 21 September 2018

Read minutes and papers of APRHAI meetings

Meetings before September 2012


Terms of reference

The APRHAI terms of reference are to:

  • provide practical and scientific advice to government on strategies to:
    • minimise the incidence of healthcare associated infections (HCAI)
    • monitor antimicrobial resistance (AMR) and reduce its development and spread
    • maintain the effectiveness of antimicrobial use (AMU) and optimise antimicrobial prescribing (AMP) in the treatment and prevention of microbial infections
  • take into account the relevant work of other expert groups, in the human and veterinary fields when making its recommendations.
  • help guide government’s scientific priorities and work, including horizon-scanning and long-range planning as well as dealing with immediate risks and opportunities
  • review and evaluate the effectiveness of the on-going work of the committee
  • provide scientific advice to the sponsor Department to support delivery of the UK AMR Strategy 2013-2018, including keeping it appraised of international scientific developments in healthcare associated infections, antimicrobial resistance and antimicrobial prescribing and usage.
  • identify any gaps in the evidence base, such as those requiring further research or surveillance
  • make its findings and recommendations available to Government, and the public in a way which aims to be comprehensive, understandable and timely
  • operate in line with the government’s principles for scientific advice and the code of practice for scientific advisory committees, including making the work of the committee open, transparent and accessible as well as strengthening public and patient engagement

Contact details